NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

"Is it possible all the delay is that we are not commercialized enough yet for manufacturing.".

That does sound like a possibility. That would be on the hopeful side of things. The side where good efficacy was seen during some kind of look at the data... (comparison to Celldex, or HE evaluating reimbursement... etc.). Huge potential positive if recent big $ went to that mfg effort for L and if the effort is successful. But other possibilities.

NWBO (LP?) did say that automation for Direct was complete, but not yet for DCVax-L. She did not indicate how close they are for L. Maybe awaiting approval of a developed method, or maybe still developing a method. Other possibilities?